You're leading clinical operations for a Phase III trial. A site reports an unexpected serious adverse event. The medical monitor thinks it may not be drug-related but can't confirm for 48 hours. Your CMO asks whether to pause enrollment. What do you recommend and why?

Question

Answer

Stay specific. One example, told well, beats three told fast. Make your decisions visible — what you chose between. End on what changed, for whom.

You're leading clinical operations for a Phase III trial. A site reports an unexpected serious adverse event. The medical monitor thinks it may not be drug-related but can't confirm for 48 hours. Your CMO asks whether to pause enrollment. What do you recommend and why?

Practice more